Radiolabeled Compounds for Diagnosis and Treatment of Cancer - Mdpi Ag - Libros - MDPI AG - 9783036524276 - 6 de diciembre de 2021
En caso de que portada y título no coincidan, el título será el correcto

Radiolabeled Compounds for Diagnosis and Treatment of Cancer

Precio
$ 62,49
sin IVA

Pedido desde almacén remoto

Entrega prevista 19 de jun. - 8 de jul.
Añadir a tu lista de deseos de iMusic

Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.

Medios de comunicación Libros     Hardcover Book   (Libro con lomo y cubierta duros)
Publicado 6 de diciembre de 2021
ISBN13 9783036524276
Editores MDPI AG
Páginas 262
Dimensiones 169 × 244 × 22 mm   ·   766 g
Lengua Inglés  

Mas por Mdpi Ag

Mostrar todo

Mere med samme udgiver